Sample: What tobacco product was most commonly used among US adults in 2018? E-cigarettes? Traditional cigarettes? Neither? The answer may surprise.
Orforglipron, Investigational Oral GLP-1, Cut HbA1c and Body Weight in People with T2D
ADA 2025: Orforglipron lowered HbA1C by an average of 1.3% to 1.6% across doses, with improvements seen as early as 4 weeks, in a phase 3 trial.
The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment
Clinical insights on cannabis and dementia, hormonal contraceptives and postpartum depression, the FDA-approved blood test for Alzheimer disease, more.
Weight Cycling Ups Risk for Heart Failure by 50%, Other Metabolic Diseases by Up to 30%: New Data
Weight cycling significantly raises heart failure and metabolic disease risks, independent of baseline overweight, underscoring the importance of stable weight strategies.
The Weekly Dose: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship
Discover the latest breakthroughs in clinical research, from at-home cancer screening to AI advancements in mammography, shaping future healthcare practices.
FDA Approves Clesrovimab for RSV LRTD Prevention in Infants: Daily Dose
Your daily dose of the clinical news you may have missed.
ADA Standards of Care for Overweight and Obesity to Debut at 2025 Scientific Sessions
The ADA unveils the association's first Standards of Care for Overweight and Obesity, with a chapter on weight stigma and bias one of the first released.